RhumbLine Advisers’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.5M Buy
339,719
+56,291
+20% +$2.27M 0.01% 886
2025
Q4
$10.6M Buy
283,428
+150,889
+114% +$5.06M 0.01% 1034
2025
Q3
$3.92M Buy
132,539
+7,881
+6% +$183K ﹤0.01% 1557
2025
Q2
$2.94M Buy
124,658
+47,558
+62% +$992K ﹤0.01% 1673
2025
Q1
$1.39M Buy
77,100
+3,517
+5% +$69.1K ﹤0.01% 2009
2024
Q4
$1.25M Buy
73,583
+1,118
+2% +$19.3K ﹤0.01% 2122
2024
Q3
$1.06M Sell
72,465
-1,178
-2% -$14.8K ﹤0.01% 2236
2024
Q2
$837K Buy
73,643
+12,479
+20% +$136K ﹤0.01% 2337
2024
Q1
$665K Buy
+61,164
New +$612K ﹤0.01% 2487

Other funds holding BTSG

RhumbLine Advisers's BTSG Position: Q1 2026 in Review

RhumbLine Advisers increased its BrightSpring Health Services (BTSG) stake by 20% in Q1 2026, buying an estimated $2.27M and bringing the position to 339,719 shares worth $14.5M. The position accounts for 0.01% of the portfolio, ranked #886.

RhumbLine Advisers first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • RhumbLine Advisers held 339,719 shares of BrightSpring Health Services worth $14.5M as of Q1 2026.
  • RhumbLine Advisers bought 56,291 BrightSpring Health Services shares in Q1 2026, an estimated $2.27M.
  • BrightSpring Health Services made up 0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #886 holding.
  • RhumbLine Advisers first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.